Septerna, Inc. (SEPN) Price & Analysis

Compare

28 Followers

SEPN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$4.17 - $28.99

Previous CloseN/A

Volume49.14K

Average Volume (3M)247.04K

Market Cap

$311.10M

Enterprise Value$416.13M

Total Cash (Recent Filing)$88.48M

Total Debt (Recent Filing)$12.57M

Price to Earnings (P/E)―

Beta1.88

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding44,442,497

10 Day Avg. Volume181,628

30 Day Avg. Volume247,036

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

Price to Cash Flow (P/CF)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.34

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit387.10

Enterprise Value/Ebitda-11.80

Forecast

1Y Price Target

$19.00

Price Target Upside171.43% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

---

Septerna, Inc. News

PremiumCompany Announcements

Septerna, Inc. Reports 2024 Financial Results and Strategic Progress

1M ago

SEPN

PremiumThe Fly

Septerna price target lowered to $11 from $14 at Wells Fargo

1M ago

SEPN

PremiumThe Fly

Septerna reports Q4 EPS (64c), consensus (69c)

1M ago

SEPN

PremiumThe Fly

Septerna sees cash runway into early 2028

1M ago

SEPN

PremiumCompany Announcements

Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist

2M ago

SEPN

PremiumRatings

Hold Rating for Septerna, Inc. Amid Lead Program Discontinuation and Pipeline Uncertainty

2M ago

SEPN

PremiumThe Fly

Wells Fargo downgrades Septerna after lead program SEP-786 discontinued

2M ago

SEPN

PremiumThe Fly

Septerna downgraded to Equal Weight from Overweight at Wells Fargo

2M ago

SEPN

See All SEPN News

---

Bulls Say, Bears Say

Bulls Say

Financial StabilitySepterna has approximately $421M in cash, providing sufficient financing into early 2028.

Pipeline ProgressSEP-631 (MRGPRX2 NAM) remains on track to enter the clinic, indicating progress in the company's pipeline.

Technological InnovationSEPN is applying its Native Complex platform to build a pipeline of oral small molecule GPCR drugs, indicating significant potential for stock appreciation.

Bears Say

Lack Of Immediate CatalystsWith the lack of catalysts in the next 12-18 months, analysts move to the sidelines.

Lead Program ConcernsThe stock may trade down sharply as SEP-786 was SEPN's lead program and nearest data catalyst.

Program DiscontinuationSEPN plans to discontinue their SEP-786 program due to unanticipated increases in unconjugated serum bilirubin.

---

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

24.41% Insiders

0.29% Mutual Funds

― Other Institutional Investors

73.30% Public Companies and

Individual Investors

Detailed Ownership Overview >

SEPN FAQ

What was Septerna, Inc.’s price range in the past 12 months?

Septerna, Inc. lowest stock price was $4.17 and its highest was $28.99 in the past 12 months.

What is Septerna, Inc.’s market cap?

Septerna, Inc.’s market cap is $311.10M.

When is Septerna, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Septerna, Inc.’s earnings last quarter?

Septerna, Inc. released its earnings results on Nov 20, 2024. The company reported -$8.4 earnings per share for the quarter, missing the consensus estimate of -$5.877 by -$2.523.

Is Septerna, Inc. overvalued?

According to Wall Street analysts Septerna, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Septerna, Inc. pay dividends?

Septerna, Inc. does not currently pay dividends.

What is Septerna, Inc.’s EPS estimate?

Septerna, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Septerna, Inc. have?

Septerna, Inc. has 44,442,497 shares outstanding.

What happened to Septerna, Inc.’s price movement after its last earnings report?

Septerna, Inc. reported an EPS of -$8.4 in its last earnings report, missing expectations of -$5.877. Following the earnings report the stock price went up 2.443%.

Which hedge fund is a major shareholder of Septerna, Inc.?

Currently, no hedge funds are holding shares in SEPN

---

Septerna, Inc. Stock Smart Score

Outperform

Company Description

Septerna, Inc.

Septerna, Inc. (SEPN) is a biotechnology company focused on drug discovery and development, particularly targeting G protein-coupled receptors (GPCRs). GPCRs are a large family of cell surface receptors that play a crucial role in human physiology and are involved in a wide range of diseases. Septerna leverages its proprietary technology to develop innovative therapies aimed at addressing unmet medical needs in various therapeutic areas.

---

SEPN Stock 12 Month Forecast

Average Price Target

$19.00

▲(171.43% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","28":"$28","10.75":"$10.75","16.5":"$16.5","22.25":"$22.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$11.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,10.75,16.5,22.25,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"Mar<br/>2025","25":"Mar<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.47,8.04923076923077,9.628461538461538,11.207692307692309,12.786923076923078,14.366153846153846,15.945384615384615,17.524615384615384,19.103846153846153,20.68307692307692,22.26230769230769,23.84153846153846,25.42076923076923,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.47,7.4338461538461535,8.397692307692308,9.361538461538462,10.325384615384616,11.28923076923077,12.253076923076923,13.216923076923077,14.180769230769231,15.144615384615385,16.10846153846154,17.072307692307692,18.036153846153848,{"y":19,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.47,6.818461538461539,7.1669230769230765,7.515384615384615,7.863846153846154,8.212307692307693,8.560769230769232,8.909230769230769,9.257692307692308,9.606153846153846,9.954615384615384,10.303076923076922,10.651538461538461,{"y":11,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.75,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.75,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.79,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.79,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.91,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.47,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >